Skip to main content

Table 1 Calibration parameters of the acylcarnitines and oxysterols in the homogenate of erythrocytes

From: Accumulation of oxysterols in the erythrocytes of COVID-19 patients as a biomarker for case severity

tR, min

Name

Squared Regression coefficient, r2

Slope*

Intercept

Range, ng/μL

LOD, ng/μL

25.82

O-Palmitoleoyl-L-carnitine

0.9991

0.0425

0.0355

2.0–60

0.50

30.94

Palmitoyl-L-carnitine

0.9988

0.0399

0.0415

2.0–60

0.50

28.71

Linoleoyl-L-carnitine

0.9995

0.0517

0.0222

2.0–60

0.50

32.52

Oleoyl-L-carnitine

0.9999

0.0401

0.0066

2.0–60

0.50

37.64

Stearoyl-L-carnitine

0.9992

0.0452

0.0299

2.0–60

0.50

16.72

3-Hydroxyoleoylcarnitine

0.9987

0.0407

0.0425

2.0–60

0.50

32.55

Oleoyl-L-carnitine-d9, IS1

N/A

N/A

N/A

N/A

N/A

60.61

Cholesterol

0.9999

0.0417

0.0101

2.0–60

0.50

49.11

4,6-Cholestadien-3-one

0.9995

0.0398

0.0211

2.0–60

0.50

38.52

4β-Hydroxycholesterol-4-acetate

0.9997

0.0335

0.0198

2.0–60

0.50

38.82

4β-Hydroxycholesterol

0.9991

0.0392

0.0324

2.0–60

0.50

50.28

4-Cholestenone

0.9998

0.0378

0.0060

2.0–60

0.50

40.19

7-Ketocholesterol

0.9999

0.0414

0.0022

2.0–60

0.50

60.82

Cholesterol-d6, IS2

N/A

N/A

N/A

N/A

N/A

40.22

7-ketocholesterol-d7, IS3

N/A

N/A

N/A

N/A

N/A

  1. *The regression line was drawn by plotting the concentration (X independent variable), ng/μL, versus the peak area ratio of the analyte to the internal standard (Y dependent variable)